Scheen Scheen AJ AJ Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus Drugs Drugs 2015 2015 75 75 33 33 59 59 10.1007/s40265-014-0337-y 10.1007/s40265-014-0337-y supplied-pmid 25488697? This evidence concerns the gene SLC5A2 and diabetes mellitus.